BAY1817080

Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets
BioSpace
Fri, 02/4/22 - 11:09 am
Bayer
Evotec
BAY1817080
eliapixant